Resultados globales: 1 registros encontrados en 0.02 segundos.
Artículos, Encontrados 1 registros
Artículos Encontrados 1 registros  
1.
15 p, 594.2 KB A genetic variant in Rassf1a predicts outcome in mCRC patients treated with cetuximab plus chemotherapy : results from FIRE-3 and JACCRO 05 and 06 trials / Sebio, A. (Institut d'Investigació Biomèdica Sant Pau) ; Stintzing, S. (Department of Hematology and Oncology, Klinikum der Universitat, University of Munich,) ; Heinemann, V. (Department of Hematology and Oncology, Klinikum der Universitat, University of Munich,) ; Sunakawa, Y. (Keck School of Medicine, University of Southern California) ; Zhang, W. (Keck School of Medicine, University of Southern California) ; Ichikawa, W. (Division of Medical Oncology, Showa University) ; Tsuji, A. (Department of Clinical Oncology, Kagawa University) ; Takahashi, T. (Division of Medical Oncology, Showa University) ; Parek, A. (Keck School of Medicine, University of Southern California) ; Yang, D. (Keck School of Medicine, University of Southern California) ; Cao, S. (Keck School of Medicine, University of Southern California) ; Ning, Y. (Keck School of Medicine, University of Southern California) ; Stremitzer, S. (Keck School of Medicine, University of Southern California) ; Matsusaka, S. (Keck School of Medicine, University of Southern California) ; Okazaki, S. (Keck School of Medicine, University of Southern California) ; Barzi, A. (Keck School of Medicine, University of Southern California) ; Berger, M. (Keck School of Medicine, University of Southern California) ; Lenz, H-J (Keck School of Medicine, University of Southern California)
The Hippo pathway is involved in colorectal cancer (CRC) development and progression. The Hippo regulator Rassf1a is also involved in the Ras signaling cascade. In this work, we tested single nucleotide polymorphisms within Hippo components and their association with outcome in CRC patients treated with cetuximab. [...]
2016 - 10.1038/tpj.2016.69
The pharmacogenomics journal, october 2016  

¿Le interesa recibir alertas sobre nuevos resultados de esta búsqueda?
Defina una alerta personal vía correo electrónico o subscríbase al canal RSS.